Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

被引：0
|
作者：
Hui, C. [1 ]
Qu, V. [2 ]
Wang, J. Y. [2 ]
Von Eyben, R. [3 ]
Chang, Y. C. [4 ]
Chiang, P. L. [4 ]
Liang, C. H. [4 ]
Lin, J. Y. [4 ]
Lu, J. T. [4 ]
Li, G. [5 ]
Hayden, M. [5 ]
Myall, N. [6 ]
Soltys, S. G. [7 ]
Pollom, E. [3 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Radiat Oncol, Palo Alto, CA 94304 USA
[3] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[4] Vysioneer Inc, Cambridge, MA USA
[5] Stanford Canc Inst, Dept Neurosurg, Stanford, CA USA
[6] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2120
引用
收藏
页码：E54 / E55
页数：2
相关论文
共 50 条
  • [21] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    BMC CANCER, 2022, 22 (01)
  • [22] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Soei Gen
    Ichidai Tanaka
    Masahiro Morise
    Junji Koyama
    Yuta Kodama
    Akira Matsui
    Ayako Miyazawa
    Tetsunari Hase
    Yoshitaka Hibino
    Toshihiko Yokoyama
    Tomoki Kimura
    Norio Yoshida
    Mitsuo Sato
    Naozumi Hashimoto
    BMC Cancer, 22
  • [23] The past, present, and future management of brain metastases in EGFR-mutant non-small cell lung cancer
    Sperduto, Paul W.
    Lou, Emil
    NEURO-ONCOLOGY, 2021, 23 (06) : 867 - 868
  • [24] Aumolertinib with chemotherapy or alone compared with osimertinib in patients with EGFR-mutant non-small-cell lung cancer (TREBLE).
    Johnson, Melissa Lynne
    Miller, Vincent A.
    Patel, Suraj
    Zhao, Yumin
    Cheng, Li
    Ali, Siraj Mahamed
    Wooten, Michael
    Daniel, Davey B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Inomata, Minehiko
    Matsumoto, Masahiro
    Mizushima, Isami
    Hayashi, Kana
    Seto, Zenta
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Hayashi, Ryuji
    Matsui, Shoko
    Tobe, Kazuyuki
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2022, 16 (01)
  • [26] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chiang, Chi-Lu
    Ho, Hsiang-Ling
    Yeh, Yi-Chen
    Lee, Cheng-Chia
    Huang, Hsu-Ching
    Shen, Chia-, I
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiu, Chao-Hua
    Chou, Teh-Ying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 5 - 14
  • [27] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chi-Lu Chiang
    Hsiang-Ling Ho
    Yi-Chen Yeh
    Cheng-Chia Lee
    Hsu-Ching Huang
    Chia-I Shen
    Yung-Hung Luo
    Yuh-Min Chen
    Chao-Hua Chiu
    Teh-Ying Chou
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5 - 14
  • [28] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Minehiko Inomata
    Masahiro Matsumoto
    Isami Mizushima
    Kana Hayashi
    Zenta Seto
    Kotaro Tokui
    Chihiro Taka
    Seisuke Okazawa
    Kenta Kambara
    Shingo Imanishi
    Toshiro Miwa
    Ryuji Hayashi
    Shoko Matsui
    Kazuyuki Tobe
    The Egyptian Journal of Bronchology, 2022, 16
  • [29] Local Ablative Therapy for Oligoprogressive, EGFR-Mutant, Non-Small Cell Lung Cancer (NSCLC) After Treatment with Osimertinib
    Kim, C.
    Roper, N.
    Hoang, C.
    Connolly, M.
    Cultraro, C.
    Szabo, E.
    Waris, M.
    Padiernos, E.
    Kesarwala, A.
    Gao, S.
    Steinberg, S.
    Wong, D.
    Khan, J.
    Rajan, A.
    Guha, U.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2146 - S2146
  • [30] Local ablative therapy for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib
    Kim, Chul
    Roper, Nitin
    Chuong Hoang
    Wisch, Laura
    Connolly, Maureen
    Chou, Hsien-Chao
    Wei, Jun
    Tyagi, Manoj
    Cultraro, Constance M.
    Xi, Liqiang
    Waris, Maryam
    Khoa Dang Nguyen
    Szabo, Eva
    Padiernos, Emerson
    Kesarwala, Aparna
    Gao, Shaojian
    Steinberg, Seth M.
    Raffeld, Mark
    Rajan, Arun
    Khan, Javed
    Guha, Udayan
    CANCER RESEARCH, 2018, 78 (13)
12345